161 related articles for article (PubMed ID: 33073340)
21. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.
van Houdt WJ; Fiore M; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss D; Gonzalez RJ; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Schrage Y; Cardona K; Pennacchioli E; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria SP; Canter R; Mullen JT; Callegaro D; Fairweather M; Miceli R; Raut CP; Gronchi A; Gladdy RA
Cancer; 2020 Nov; 126(22):4917-4925. PubMed ID: 32797703
[TBL] [Abstract][Full Text] [Related]
22. Survival outcomes of surgery for retroperitoneal sarcomas: A systematic review and meta-analysis.
Guo Q; Zhao J; Du X; Huang B
PLoS One; 2022; 17(7):e0272044. PubMed ID: 35901187
[TBL] [Abstract][Full Text] [Related]
23. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
[TBL] [Abstract][Full Text] [Related]
24. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
[TBL] [Abstract][Full Text] [Related]
25. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
[TBL] [Abstract][Full Text] [Related]
26. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
27. Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis.
Nizri E; Fiore M; Colombo C; Radaelli S; Callegaro D; Sanfilippo R; Sangalli C; Collini P; Morosi C; Stacchiotti S; Casali PG; Gronchi A
J Surg Oncol; 2019 Mar; 119(3):318-323. PubMed ID: 30554403
[TBL] [Abstract][Full Text] [Related]
28. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative.
Thalji SZ; Tsai S; Gamblin TC; Clarke C; Christians K; Charlson J; Ethun CG; Poultsides G; Grignol VP; Roggin KK; Votanopoulos K; Fields RC; Abbott DE; Cardona K; Mogal H;
J Surg Oncol; 2020 Jun; 121(7):1140-1147. PubMed ID: 32167587
[TBL] [Abstract][Full Text] [Related]
30. Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes.
Grobmyer SR; Wilson JP; Apel B; Knapik J; Bell WC; Kim T; Bland KI; Copeland EM; Hochwald SN; Heslin MJ
J Am Coll Surg; 2010 May; 210(5):602-8, 608-10. PubMed ID: 20421013
[TBL] [Abstract][Full Text] [Related]
31. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival.
Lehnert T; Cardona S; Hinz U; Willeke F; Mechtersheimer G; Treiber M; Herfarth C; Buechler MW; Schwarzbach MH
Eur J Surg Oncol; 2009 Sep; 35(9):986-93. PubMed ID: 19138832
[TBL] [Abstract][Full Text] [Related]
32. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
[TBL] [Abstract][Full Text] [Related]
33. Aggressive and frequent resection of recurrences in retroperitoneal sarcoma contributes to long-term survival.
Komori K; Tsukushi S; Yoshida M; Kinoshita T; Oshiro T; Ouch A; Ito S; Abe T; Misawa K; Ito Y; Natsume S; Higaki E; Okuno M; Hosoi T; Shoji K; Kunitomo A; Oki S; Suenaga Y; Maeda S; Nagao T; Dei H; Numata Y; Aritake T; Tawada K; Shimizu Y
Langenbecks Arch Surg; 2021 Aug; 406(5):1635-1642. PubMed ID: 33449172
[TBL] [Abstract][Full Text] [Related]
34. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
[TBL] [Abstract][Full Text] [Related]
35. Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.
Malinka T; Nebrig M; Klein F; Pratschke J; Bahra M; Andreou A
BMC Surg; 2019 Jun; 19(1):61. PubMed ID: 31182086
[TBL] [Abstract][Full Text] [Related]
36. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
Erzen D; Sencar M; Novak J
J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.
Wilkinson KH; Ethun CG; Hembrook M; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Weber S; Gamblin TC; Cardona K; Clarke CN
J Surg Res; 2019 Jan; 233():154-162. PubMed ID: 30502242
[TBL] [Abstract][Full Text] [Related]
38. Impact of time to first relapse on long-term outcome in adult retroperitoneal sarcoma patients after radical resection.
Guan H; Liu M; Cai S; Ou B; Guan Y; Liang Y
Int J Clin Oncol; 2022 Sep; 27(9):1487-1498. PubMed ID: 35763227
[TBL] [Abstract][Full Text] [Related]
39. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
[TBL] [Abstract][Full Text] [Related]
40. Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre.
Snow HA; Hitchen TX; Head J; Herschtal A; Bae S; Chander S; Chu J; Hendry S; Ngan SY; Desai J; Choong PFM; Henderson M; Gyorki DE
ANZ J Surg; 2018 Nov; 88(11):1151-1157. PubMed ID: 30288891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
